世界における治験用材料・サンプルの供給・物流サービス市場...市場調査レポートについてご紹介

【英文タイトル】Clinical Trial Supply And Logistics: World Industry And Market Outlook 2015-2025

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

1. Report Overview
1.1 Overview of the World Market Clinical Trial Supply and Logistics
1.2 Why You Should Read This Report
1.3 How This Report Delivers
1.4 Main Questions Answered by this Analysis
1.5 Who Is This Study For?
1.6 Methods of Research and Analysis
1.7 Frequently Asked Questions (FAQs)
1.8 Some Associated Reports
1.9 About Visiongain

2. Defining the Clinical Trial Supply and Logistics Market
2.1 An Introduction to the Clinical Trial Supply and Logistics Market
2.2 Clinical Trials are Becoming Increasingly Complex
2.3 Clinical Trial Globalisation: Access to New Markets and New Patients
2.4 Outsourcing Clinical Trial Supply and Logistics
2.5 What Services Are Most Commonly Outsourced?
2.6 Which Companies Participate in the Clinical Trial Supply and Logistics Market?
2.7 Clinical Trial Supply and Logistics: Trends and Future Outlook

3. Clinical Trial Supply and Logistics: World Market Outlook and Forecasting 2015-2025
3.1 The World Clinical Trial Supply and Logistics Market 2013
3.1.1 Which Were the Leading Market Sectors in 2013?
3.2 The World Clinical Trial Supply and Logistics Market Forecast 2015-2025
3.2.1 What Will Drive Market Growth to 2025?
3.2.2 Clinical Trial Supply and Logistics: Market Restraints 2015-2025
3.3 Clinical Trial Manufacturing Submarket 2015-2025
3.3.1 Outlook and Forecast for the Clinical Trial Manufacturing Submarket 2015-2025
3.3.2 Complex Manufacturing and Packaging to Drive Growth 2015-2025
3.3.3 Clinical Trial Packaging Submarket Forecast 2015-2025
3.4 Clinical Trial Logistics and Distribution Submarket 2015-2025
3.4.1 Clinical Trial Logistics and Distribution Submarket Forecast 2015-2025
3.4.2 Submarket Drivers and Restraints 2015-2025
3.4.3 Clinical Trial Cold Chain Distribution Submarket Forecast 2015-2025
3.5 Clinical Trial Supply Chain Management Submarket 2015-2025
3.5.1 Clinical Trial Supply Chain Management Submarket Forecast 2015-2025
3.5.2 Drivers and Restraints for the Clinical Trial Supply Chain Management Submarket 2015-2025

4. Leading National Markets for Clinical Trial Supply and Logistics 2015-2025
4.1 Defining National Submarkets for Clinical Trial Supply and Logistics
4.2 Leading National Submarkets for Clinical Trial Supply and Logistics 2013
4.2.1 How Will These Leading Submarkets Grow 2015-2025?
4.3 Clinical Trial Supply and Logistics in the US 2015-2025
4.3.1 How Will Demand for Clinical Trial Logistics Grow in the US to 2025?
4.4 Western Europe
4.4.1 Western Europe: Clinical Trial Supply and Logistics Submarket Forecast 2015-2025
4.4.2 The EU5: National Submarket Forecasts 2015-2025
4.5 Japan: A New and Growing Market for Outsourced Logistics
4.5.1 Japanese Clinical Trial Supply and Logistics Submarket Forecast 2015-2025
4.6 Clinical Trial Supply in Emerging National Markets
4.7 The Latin American Clinical Trial Supply and Logistics Market 2015-2025
4.7.1 Challenging Distribution Conditions
4.7.2 Brazilian Clinical Trial Supply and Logistics Submarket Forecast 2015-2025
4.8 Russia and Central and Eastern Europe (CEE)
4.8.1 Outsourcing Will Grow Strongly in Russia
4.8.2 Russian Clinical Trial Supply and Logistics Submarket Forecast 2015-2025
4.9 India: An Emerging Destination for Outsourced Clinical Trials
4.9.1 New Clinical Trial Rules Restrain Growth in 2013
4.9.2 Indian Clinical Trial Supply and Logistics Submarket Forecast 2015-2025
4.10 Clinical Trial Supply and Logistics in China 2015-2025
4.10.1 Foreign Investment in Chinese Clinical Trial Logistics
4.10.2 Strong Growth for Clinical Trial Supply and Logistics in China 2015-2025

5. Clinical Trial Supply and Logistics: Regulatory Outlook 2015-2025
5.1 How do Regulatory Standards Affect Clinical Trial Supply?
5.1.1 Good Practices (GxP) in Clinical Trial Distribution
5.1.1.1 Good Manufacturing Practice (GMP)
5.1.1.2 Good Distribution Practice (GDP)
5.1.2 Import Regulations Complicate International Manufacturing and Trials
5.2 Clinical Trial Supply Regulations in the US 2013
5.2.1 Importing Drugs into the US: A Reinterpretation of the Rules
5.3 Clinical Trial Regulations in the EU 2013
5.3.1 Manufacturing Requirements for Clinical Trial Materials in the EU
5.3.2 The European Commission Releases New GDP Guidelines 2013
5.4 GMP and Importation Regulations for Pharmaceuticals in Japan 2013
5.5 Clinical Trial Supply Chain Regulations in Emerging Markets
5.5.1 China: Tougher Regulations for Pharmaceutical Companies and Service Providers
5.5.1.1 Improving Supply Chain Security in China 2013
5.5.2 India: Drug Manufacturing and Imports for Clinical Trials
5.5.2.1 The CDSCO Drafts New GDP Guidelines 2013
5.5.3 Brazil: Slow Regulatory Approval for Clinical Trials
5.5.4 Recent Updates to Pharmaceutical Regulation in Russia

6. Clinical Trial Supply and Logistics: Industry Trends 2015-2025
6.1 Clinical Trial Supply and Logistics Market: Strengths and Weaknesses 2013
6.2 Clinical Trial Supply and Logistics Market: Opportunities and Threats 2015-2025
6.3 Clinical Trial Supply and Logistics Market: STEP Analysis 2015-2025
6.3.1 Social Factors
6.3.2 How Will Novel Technologies Affect the Market to 2025?
6.3.3 Economic Pressures: Demands for Lower Cost Trials and Logistics
6.3.4 Political Issues
6.4 Securing the Clinical Trial Supply Chain 2015-2025
6.4.1 How Will Technology Improve Supply Chain Security?
6.5 How Will Clinical Trial Globalisation Impact Supply and Logistics?
6.6 Trends in Clinical Trial Manufacturing 2015-2025
6.6.1 The Challenge of Comparator Sourcing for Clinical Trials
6.6.1.1 Comparators Are a Source of Risk for Supply Chain Security
6.6.1.2 Regulators and Payers Will Increasingly Demand Comparative Effectiveness Research
6.6.2 Trends in Packaging for Clinical Trials 2015-2025
6.7 Clinical Trial Supply Chain Management Trends to 2025
6.7.1 Forecasting and Modelling to Ensure Sufficient Supply
6.7.2 IT Systems Improve Clinical Trial Planning: IVRS and IWRS
6.7.3 Home-Based Trial Participation: Opportunities and Challenges for Logistics
6.7.4 How Will Greater Use of Adaptive Clinical Trials Impact Trial Logistics?
6.8 Outsourcing Clinical Trial Supply and Logistics
6.8.1 Managing Multiple Supplier Networks

7. The Rise of Cold Chain Logistics in Clinical Trials 2015-2025
7.1 An Introduction to Cold Chain Supply and Distribution
7.1.1 The Importance of Cold Chain for Clinical Trials
7.1.2 Maintaining the Cold Chain
7.2 The Regulatory Outlook for Cold Chain Logistics
7.2.1 International Air Transport Regulations and Guidance: The Temperature Sensitive Label
7.3 Cold Chain Will Account for an Increasing Proportion of Clinical Trial Logistics 2015-2025
7.3.1 Biologic Drug Development Will Stimulate Demand
7.3.1.1 Emerging Trends in Biological Drug Development
7.3.2 Pharma Cold Chain Logistics in Emerging Markets
7.4 The Role of Technology in Clinical Cold Chain Logistics
7.4.1 Active and Passive Temperature Control
7.4.2 There Are Many Ways to Maintain Temperature in the Cold Chain
7.4.2.1 Developments in Phase Change Materials
7.4.2.2 The Benefits of Liquid Nitrogen for Sample Transportation
7.4.3 Advances in RFID for Temperature Monitoring
7.4.3.1 Will Uptake for RFID Grow Among Biopharma Companies to 2025?
7.4.4 Future Technologies for Cold Chain Supply Management
7.4.4.1 Demand for Reusable Cold Chain Packaging

8. Clinical Trial Supply and Logistics Market: Leading Companies
8.1 Third Party Logistics Providers: Leading Clinical Distributors
8.1.1 World Courier: A Pharmaceutical Supply Specialist
8.1.1.1 Distribution Services for Pharma, CROs and Central Laboratories
8.1.1.2 World Courier Is the Clinical Trial Distribution Market Leader
8.1.1.3 World Courier Opens New Service Depots in Europe and Latin America 2013
8.1.2 DHL: A Global Leader in Supply Chain Logistics
8.1.2.1 Life Sciences: A Fast-Growing Source of Revenue for DHL Supply Chain
8.1.2.2 DHL Adds New Services for Healthcare and Clinical Trial Clients 2013
8.1.3 Marken
8.1.3.1 What Services Does Marken Offer Clinical Trial Sponsors?
8.1.3.2 Marken: Challenging Market Conditions 2009-2013
8.1.3.3 Marken Continues to Expand Worldwide
8.1.3.4 Expertise in Biological Sample Management
8.1.4 Other Leading and Emerging Players in the Market
8.1.4.1 TNT Express
8.1.4.2 FedEx
8.1.4.3 Movianto – a European Healthcare Specialist
8.2 Clinical Trial Manufacturing: Submarket Leaders
8.2.1 Catalent Pharma Solutions
8.2.1.1 Clinical Trial Manufacturing and Supply Services
8.2.1.2 Strong Growth for Clinical Manufacturing Revenue
8.2.1.3 Catalent Increases its Focus on Clinical Trial Manufacturing
8.2.2 Patheon
8.2.2.1 Patheon Is a Leader in Pharmaceutical Development Services
8.2.2.2 Patheon Completed 445 Clinical Projects in 2013
8.2.3 Almac Group: Manufacturing, Packaging and Logistics Services
8.2.3.1 Clinical Trial Supply and Management Solutions
8.2.3.2 Almac Opens New Facilities to Expand its Clinical Trial Expertise
8.3 The Role of CROs in the Clinical Trial Supply and Logistics Market
8.3.1 Parexel International
8.3.1.1 Parexel’s Clinical Trial Supply and Logistics Services
8.3.1.2 Parexel Expands Worldwide
8.4 Other Leading Companies in the Clinical Trial Supply and Logistics Market 2013
8.4.1 Fisher Clinical Services (FCS)
8.4.1.1 FCS Offers Manufacturing, Packaging, Storage and Distribution Services
8.4.1.2 Fisher BioServices: Clinical Logistics for the Cell Therapy Industry
8.4.2 Packaging Coordinators Inc. (PCI)

9. Research Interviews from Our Survey
9.1 Dr Pramod Kabra, General Manager and Managing Director, Fisher Clinical Services, India
9.1.1 Fisher Clinical Services
9.1.2 Trends in the Indian Clinical Research Market
9.1.3 Why India Is an Attractive Site for Drug Development
9.1.4 Challenges in Supply and Logistics in India
9.1.5 Addressing the Risk of Counterfeiting
9.1.6 Optimizing Cold Chain Services
9.1.7 Feasibility of Direct-to-Patient Distribution in India
9.1.8 Overcoming Regulatory Hurdles
9.1.9 Forward-Looking Statement
9.2 Ariette van Strien, Senior VP Commercial Operations, Marken, US
9.2.1 Marken
9.2.2 The Landscape of Emerging Markets
9.2.3 Increasing Trend Towards Direct-to-Patient Distribution
9.2.4 Expansion of Marken’s Network
9.2.5 Major Changes in This Decade
9.3 Partha Chatterjee, Global Head, Clinical Research and Clinical Trial Supplies Management, SIRO Clinpharm
9.3.1 SIRO Clinpharm
9.3.2 Clinical Trial Supply Management
9.3.3 SIRO Clinpharm’s New Office in Hyderabad
9.3.4 Challenges to be Addressed
9.3.5 On SIRO Clinpharm’s Services and Strengths
9.4 Ramesh J. Chougule. Partner and AVP – Management Consulting, LifeScience, Infosys
9.4.1 Infosys
9.4.2 Contribution from the Life Sciences Sector
9.4.3 Penetration of the Global Market
9.4.4 Challenges in Emerging Markets
9.4.5 How Will the Market Change in Five Years?

10. Conclusions of Our Study
10.1 The Clinical Trial Supply and Logistics Market 2013
10.2 Outlook for the Market 2014-2025
10.3 Growing Demand for Clinical Logistics in Emerging Countries
10.4 Technology and Innovation to Drive Outsourcing


【レポート販売概要】

■ タイトル:世界における治験用材料・サンプルの供給・物流サービス市場
■ 英文:Clinical Trial Supply And Logistics: World Industry And Market Outlook 2015-2025
■ 発行日:2015年1月
■ 調査会社:visiongain
■ 商品コード:VGAIN501166
■ 調査対象地域:グローバル
  • 世界のクロマトグラフィー用試薬市場2015
    The Global Reagents for Chromatography Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Reagents for Chromatography industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Reagents for Chromatography market analysis is provided for the international mark …
  • 体外診断(IVD)の世界市場予測(~2021):製品別、技術別(イムノアッセイ、臨床化学、分子診断、血液学)、用途別
    The global in vitro diagnostics market is estimated to reach USD 78.74 Billion by 2021, at a CAGR of 5.5% during the forecast period. The growing acceptance of molecular diagnostics for personalized medicine, increase in prevalence of chronic lifestyle diseases, and rise in demand for point-of-care testing are driving market growth. New range of condition-specific markers and tests with advances i …
  • ディーゼル商用車向け選択接触還元法(SCR)の世界市場2016-2020
    About Selective Catalytic Reduction SCR is used for controlling the emission levels of Nitrogen oxide from diesel engines. These are fitted in the exhaust system of the vehicles. SCR is a system that converts nitrogen oxides into nitrogen, carbon dioxide, and water. The system uses diesel exhaust fluid (DEF), which is essentially a liquid reductant agent that is injected into the exhaust stream of …
  • 世界の家電市場動向
    Our study Consumer Electronics focuses on video devices and explores the main technological and industrial trends in the following market segments: • Television • Computers • Portable Media Devices • Digital Media Boxes • Set-Top-Boxes. It also delivers key findings on our market sizing and forecasts for CE and connected CE, with a highlight on Ultra HD TV set sales (volume and value) and its pros …
  • Grifols, S.A.:市場シェア分析
    Grifols, S.A. Market Share Analysis Summary GlobalData’s new report, “Grifols, S.A. Market Share Analysis” provides in-depth information on Grifols, S.A.’s market position in the haematology market. The report also provides data and information on the overall competitive landscape within the haematology market. The report is supplemented with global corporate-level profile with information on the …
  • Toxoplasmosis:医療検査市場2014
    The report presents a detailed analysis of the Toxoplasmosis diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Toxoplasmosis definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the following market segments:     - Hospitals    &nb …
  • グローバルスキンケア製品市場におけるM&A動向(2014年3月)
    Synopsis The report provides a review of the mergers and acquisitions (M&As), partnering deals, and agreements entered into by companies active in the global skincare market during March 2014. Summary Using this report, dealmakers will effectively gain an insight into deal activity of the global skincare market throughout the month. Additionally, the report provides an overview of all the partneri …
  • 世界のタイヤコード市場2015
    The Global Tire Cord Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Tire Cord industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Tire Cord market analysis is provided for the international markets including development trends, competitive landscap …
  • Post-Operative Pain:グローバル臨床試験レビューH1, 2013
    Post-Operative Pain Global Clinical Trials Review, H1, 2013 Summary GlobalData's clinical trial report, “Post-Operative Pain Global Clinical Trials Review, H1, 2013" provides data on the Post-Operative Pain clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Post-Operative Pain. It includes an overview of the trial numbers and their recru …
  • 乾癬(Psoriasis)治療のグローバル市場:画期的医薬品開発
    Frontier Pharma: Psoriasis - Identifying and Commercializing First-in-Class Innovation Summary GBI Research has released the pharma report: “Frontier Pharma: Psoriasis - Identifying and Commercializing First-in-Class Innovation”, which identifies and assesses first-in-class innovation in the psoriasis development pipeline. Over the last decade, a greater understanding of the underlying pathophysio …
  • 高級ビニールタイル(LVT)フローリングの世界市場予測(~2024年)
    “Increase in the construction activities (innovation, remodeling, and maintenance) are projected to drive the overall growth of the luxury vinyl tiles (LVT) flooring market across regions from 2019 to 2024.” The LVT flooring market is projected to grow from USD 18.0 billion in 2019 to USD 31.4 billion by 2024, recording a CAGR of 11.7% from 2019 to 2024. The global LVT flooring market witnesses a …
  • 次世代バイオロジックス(生物製剤)市場:技術、産業、市場(2014-2024)
    Emerging biological drugs – discover R&D, business analysis, and revenue forecasts What’s the future of biologics, especially new drug classes? Now get the latest technological and commercial analysis. Staying ahead in data and knowledge, you benefit your authority. And you explore trends, developments, results, opportunities, and sales predictions. So visiongain’s new report shows you what’s poss …
  • 車両制御ユニットの世界市場予測(~2027年)
    “Demand for advanced electric vehicles and innovative technologies in vehicle electronics are significant factors for the growth of the vehicle control unit market globally”The global vehicle control unit market is estimated to grow from USD 2.9 billion in 2019 to reach USD 10.4 billion by 2027, at a CAGR of 17.1%. Increased emphasis on electric vehicle features and the need for integrated vehicle …
  • ケミカルタンカー輸送の北米市場分析
    The North American chemical tanker shipping market is expected to reach USD 339.5 billion by 2027, according to a new report by Grand View Research, Inc. The growing chemical products exports and low chartered rates are expected to drive the market during the forecast period. After a severe downfall in 2015 to 2016, the U.S. shale oil/gas is likely to reach its full production scale by 2018. It is …
  • 全身性エリテマトーデス/ループス腎炎治療薬の世界市場予測および分析
    PharmaPoint: Systemic Lupus Erythematosus and Lupus Nephritis - Global Drug Forecast and Market Analysis to 2022 - Event-Driven Update Summary The lupus therapeutics market is dominated by generics and GlaxoSmithKline’s Benlysta is the only drug that has gained marketing approval for SLE in more than 50 years. Following Benlysta’s launch, patients’ uptake has remained low, but due to its associate …
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。